nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimecrolimus—Asthma aggravated—Ramipril—type 1 diabetes mellitus	0.0579	0.324	CcSEcCtD
Pimecrolimus—MTOR—retina—type 1 diabetes mellitus	0.00658	0.121	CbGeAlD
Pimecrolimus—FKBP1A—retina—type 1 diabetes mellitus	0.00592	0.109	CbGeAlD
Pimecrolimus—MTOR—cardiovascular system—type 1 diabetes mellitus	0.00557	0.103	CbGeAlD
Pimecrolimus—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.00546	0.0306	CcSEcCtD
Pimecrolimus—MTOR—kidney—type 1 diabetes mellitus	0.00545	0.101	CbGeAlD
Pimecrolimus—MTOR—pancreas—type 1 diabetes mellitus	0.00541	0.0999	CbGeAlD
Pimecrolimus—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.00532	0.0298	CcSEcCtD
Pimecrolimus—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.00513	0.0288	CcSEcCtD
Pimecrolimus—FKBP1A—cardiovascular system—type 1 diabetes mellitus	0.00501	0.0924	CbGeAlD
Pimecrolimus—FKBP1A—kidney—type 1 diabetes mellitus	0.0049	0.0904	CbGeAlD
Pimecrolimus—FKBP1A—pancreas—type 1 diabetes mellitus	0.00487	0.0898	CbGeAlD
Pimecrolimus—MTOR—lymphoid tissue—type 1 diabetes mellitus	0.00468	0.0864	CbGeAlD
Pimecrolimus—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.00442	0.0248	CcSEcCtD
Pimecrolimus—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00438	0.0245	CcSEcCtD
Pimecrolimus—FKBP1A—lymphoid tissue—type 1 diabetes mellitus	0.00421	0.0777	CbGeAlD
Pimecrolimus—Influenza—Ramipril—type 1 diabetes mellitus	0.00419	0.0234	CcSEcCtD
Pimecrolimus—Asthma—Ramipril—type 1 diabetes mellitus	0.00419	0.0234	CcSEcCtD
Pimecrolimus—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00403	0.0226	CcSEcCtD
Pimecrolimus—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.00389	0.0218	CcSEcCtD
Pimecrolimus—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00382	0.0214	CcSEcCtD
Pimecrolimus—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00363	0.0203	CcSEcCtD
Pimecrolimus—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00352	0.0197	CcSEcCtD
Pimecrolimus—Sinusitis—Ramipril—type 1 diabetes mellitus	0.0035	0.0196	CcSEcCtD
Pimecrolimus—Flushing—Ramipril—type 1 diabetes mellitus	0.00311	0.0174	CcSEcCtD
Pimecrolimus—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.00303	0.017	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.00302	0.0169	CcSEcCtD
Pimecrolimus—Erythema—Ramipril—type 1 diabetes mellitus	0.00292	0.0163	CcSEcCtD
Pimecrolimus—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00292	0.0163	CcSEcCtD
Pimecrolimus—Angioedema—Ramipril—type 1 diabetes mellitus	0.00266	0.0149	CcSEcCtD
Pimecrolimus—Cough—Ramipril—type 1 diabetes mellitus	0.00254	0.0143	CcSEcCtD
Pimecrolimus—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00248	0.0139	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00247	0.0138	CcSEcCtD
Pimecrolimus—Oedema—Ramipril—type 1 diabetes mellitus	0.00238	0.0133	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00238	0.0133	CcSEcCtD
Pimecrolimus—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00233	0.0131	CcSEcCtD
Pimecrolimus—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00231	0.013	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00217	0.0121	CcSEcCtD
Pimecrolimus—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00214	0.012	CcSEcCtD
Pimecrolimus—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00212	0.0119	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00205	0.0115	CcSEcCtD
Pimecrolimus—Constipation—Ramipril—type 1 diabetes mellitus	0.00204	0.0114	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00195	0.0109	CcSEcCtD
Pimecrolimus—Urticaria—Ramipril—type 1 diabetes mellitus	0.00189	0.0106	CcSEcCtD
Pimecrolimus—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00188	0.0105	CcSEcCtD
Pimecrolimus—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00188	0.0105	CcSEcCtD
Pimecrolimus—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00175	0.00982	CcSEcCtD
Pimecrolimus—Pruritus—Ramipril—type 1 diabetes mellitus	0.00168	0.00943	CcSEcCtD
Pimecrolimus—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00163	0.00912	CcSEcCtD
Pimecrolimus—CYP3A4—kidney—type 1 diabetes mellitus	0.0016	0.0296	CbGeAlD
Pimecrolimus—Vomiting—Ramipril—type 1 diabetes mellitus	0.00151	0.00848	CcSEcCtD
Pimecrolimus—Rash—Ramipril—type 1 diabetes mellitus	0.0015	0.00841	CcSEcCtD
Pimecrolimus—Dermatitis—Ramipril—type 1 diabetes mellitus	0.0015	0.0084	CcSEcCtD
Pimecrolimus—Headache—Ramipril—type 1 diabetes mellitus	0.00149	0.00835	CcSEcCtD
Pimecrolimus—Nausea—Ramipril—type 1 diabetes mellitus	0.00141	0.00792	CcSEcCtD
Pimecrolimus—MTOR—Signaling by FGFR in disease—TYK2—type 1 diabetes mellitus	0.000652	0.000849	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—ERBB3—type 1 diabetes mellitus	0.00065	0.000847	CbGpPWpGaD
Pimecrolimus—MTOR—PI3K/AKT activation—EGFR—type 1 diabetes mellitus	0.00065	0.000847	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR—TYK2—type 1 diabetes mellitus	0.000646	0.000842	CbGpPWpGaD
Pimecrolimus—MTOR—GAB1 signalosome—EGFR—type 1 diabetes mellitus	0.000645	0.00084	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—G6PC2—type 1 diabetes mellitus	0.000641	0.000835	CbGpPWpGaD
Pimecrolimus—MTOR—BDNF signaling pathway—CASP3—type 1 diabetes mellitus	0.000641	0.000835	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR in Cancer—TYK2—type 1 diabetes mellitus	0.00064	0.000834	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by PDGF—TYK2—type 1 diabetes mellitus	0.000637	0.000831	CbGpPWpGaD
Pimecrolimus—MTOR—ErbB1 downstream signaling—EGFR—type 1 diabetes mellitus	0.00063	0.000821	CbGpPWpGaD
Pimecrolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—type 1 diabetes mellitus	0.00063	0.000821	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—B2M—type 1 diabetes mellitus	0.000619	0.000806	CbGpPWpGaD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—CASP3—type 1 diabetes mellitus	0.000617	0.000804	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—APOC3—type 1 diabetes mellitus	0.000616	0.000803	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—IAPP—type 1 diabetes mellitus	0.000616	0.000803	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—CDK4—type 1 diabetes mellitus	0.000595	0.000775	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—B2M—type 1 diabetes mellitus	0.000594	0.000774	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—B2M—type 1 diabetes mellitus	0.000592	0.000771	CbGpPWpGaD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—TYK2—type 1 diabetes mellitus	0.000577	0.000752	CbGpPWpGaD
Pimecrolimus—MTOR—IRS-mediated signalling—IL6—type 1 diabetes mellitus	0.000573	0.000747	CbGpPWpGaD
Pimecrolimus—MTOR—IRS-related events—IL6—type 1 diabetes mellitus	0.000558	0.000727	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000553	0.000721	CbGpPWpGaD
Pimecrolimus—MTOR—IRS-related events triggered by IGF1R—IL6—type 1 diabetes mellitus	0.000553	0.00072	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by SCF-KIT—STAT3—type 1 diabetes mellitus	0.000547	0.000713	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000547	0.000713	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000547	0.000713	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CBLB—type 1 diabetes mellitus	0.000542	0.000706	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—HLA-E—type 1 diabetes mellitus	0.000538	0.000702	CbGpPWpGaD
Pimecrolimus—MTOR—BDNF signaling pathway—STAT3—type 1 diabetes mellitus	0.000538	0.000702	CbGpPWpGaD
Pimecrolimus—MTOR—Insulin receptor signalling cascade—IL6—type 1 diabetes mellitus	0.000538	0.000701	CbGpPWpGaD
Pimecrolimus—MTOR—IGF1R signaling cascade—IL6—type 1 diabetes mellitus	0.000538	0.000701	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—CD80—type 1 diabetes mellitus	0.000526	0.000685	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—HLA-DPB1—type 1 diabetes mellitus	0.000525	0.000685	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—HLA-E—type 1 diabetes mellitus	0.000517	0.000674	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000514	0.00067	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—SELL—type 1 diabetes mellitus	0.000512	0.000667	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL1R1—type 1 diabetes mellitus	0.000499	0.00065	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CTLA4—type 1 diabetes mellitus	0.000498	0.000649	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by SCF-KIT—EGFR—type 1 diabetes mellitus	0.000498	0.000648	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—NOS1—type 1 diabetes mellitus	0.000496	0.000646	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signal transduction—STAT3—type 1 diabetes mellitus	0.000492	0.000642	CbGpPWpGaD
Pimecrolimus—MTOR—EGF/EGFR Signaling Pathway—STAT3—type 1 diabetes mellitus	0.00049	0.000638	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—PRKCQ—type 1 diabetes mellitus	0.000486	0.000633	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—IL6—type 1 diabetes mellitus	0.000484	0.000631	CbGpPWpGaD
Pimecrolimus—MTOR—VEGFA-VEGFR2 Pathway—IL6—type 1 diabetes mellitus	0.000477	0.000621	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling of activated FGFR—EGFR—type 1 diabetes mellitus	0.000476	0.00062	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CD79A—type 1 diabetes mellitus	0.000475	0.000619	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—VAV1—type 1 diabetes mellitus	0.000472	0.000615	CbGpPWpGaD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—EGFR—type 1 diabetes mellitus	0.000471	0.000614	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB4—EGFR—type 1 diabetes mellitus	0.000469	0.000611	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—PRKCQ—type 1 diabetes mellitus	0.000466	0.000608	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—PRKCQ—type 1 diabetes mellitus	0.000464	0.000605	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000461	0.000601	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR in disease—STAT3—type 1 diabetes mellitus	0.000456	0.000595	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—VAV1—type 1 diabetes mellitus	0.000453	0.00059	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—VAV1—type 1 diabetes mellitus	0.000451	0.000588	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by VEGF—IL6—type 1 diabetes mellitus	0.00045	0.000587	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signal transduction—EGFR—type 1 diabetes mellitus	0.000447	0.000583	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by Insulin receptor—IL6—type 1 diabetes mellitus	0.000447	0.000583	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by PDGF—STAT3—type 1 diabetes mellitus	0.000446	0.000582	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR—EGFR—type 1 diabetes mellitus	0.000445	0.00058	CbGpPWpGaD
Pimecrolimus—MTOR—EGF/EGFR Signaling Pathway—EGFR—type 1 diabetes mellitus	0.000445	0.00058	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—TYK2—type 1 diabetes mellitus	0.000444	0.000579	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB2—EGFR—type 1 diabetes mellitus	0.000443	0.000577	CbGpPWpGaD
Pimecrolimus—CYP3A4—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000442	0.000576	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 signaling—EGFR—type 1 diabetes mellitus	0.000441	0.000575	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—HLA-DQA1—type 1 diabetes mellitus	0.000438	0.000571	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—EGFR—type 1 diabetes mellitus	0.000435	0.000566	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000434	0.000566	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000432	0.000563	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000432	0.000563	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—LGALS3—type 1 diabetes mellitus	0.00042	0.000548	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 interactions—EGFR—type 1 diabetes mellitus	0.000415	0.000541	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR in disease—EGFR—type 1 diabetes mellitus	0.000415	0.000541	CbGpPWpGaD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—EGFR—type 1 diabetes mellitus	0.000415	0.000541	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—CD86—type 1 diabetes mellitus	0.000411	0.000536	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR—EGFR—type 1 diabetes mellitus	0.000411	0.000536	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—HLA-DQB1—type 1 diabetes mellitus	0.00041	0.000534	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR in Cancer—EGFR—type 1 diabetes mellitus	0.000407	0.000531	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by PDGF—EGFR—type 1 diabetes mellitus	0.000406	0.000529	CbGpPWpGaD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—STAT3—type 1 diabetes mellitus	0.000404	0.000527	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—ITPR3—type 1 diabetes mellitus	0.000401	0.000523	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IFIH1—type 1 diabetes mellitus	0.000399	0.000519	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CD86—type 1 diabetes mellitus	0.000395	0.000515	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—CD86—type 1 diabetes mellitus	0.000393	0.000512	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—SLC11A1—type 1 diabetes mellitus	0.000388	0.000506	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CD40LG—type 1 diabetes mellitus	0.000387	0.000505	CbGpPWpGaD
Pimecrolimus—MTOR—B Cell Activation—EGFR—type 1 diabetes mellitus	0.000384	0.0005	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—HLA-B—type 1 diabetes mellitus	0.000384	0.0005	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CD8A—type 1 diabetes mellitus	0.000383	0.000499	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by SCF-KIT—IL6—type 1 diabetes mellitus	0.000382	0.000498	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—SST—type 1 diabetes mellitus	0.000379	0.000494	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000377	0.000492	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—ERBB3—type 1 diabetes mellitus	0.000371	0.000483	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—ITPR3—type 1 diabetes mellitus	0.000371	0.000483	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—CASP3—type 1 diabetes mellitus	0.00037	0.000482	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—HLA-B—type 1 diabetes mellitus	0.000368	0.00048	CbGpPWpGaD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—EGFR—type 1 diabetes mellitus	0.000367	0.000479	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling of activated FGFR—IL6—type 1 diabetes mellitus	0.000366	0.000477	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—PTPN2—type 1 diabetes mellitus	0.000365	0.000475	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—B2M—type 1 diabetes mellitus	0.00036	0.00047	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB4—IL6—type 1 diabetes mellitus	0.00036	0.000469	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—ERBB3—type 1 diabetes mellitus	0.000356	0.000464	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—ERBB3—type 1 diabetes mellitus	0.000355	0.000462	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—CCR5—type 1 diabetes mellitus	0.000349	0.000454	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—IAPP—type 1 diabetes mellitus	0.000347	0.000452	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—APOC3—type 1 diabetes mellitus	0.000347	0.000452	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signal transduction—IL6—type 1 diabetes mellitus	0.000344	0.000448	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR—IL6—type 1 diabetes mellitus	0.000342	0.000446	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—HLA-A—type 1 diabetes mellitus	0.000341	0.000445	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB2—IL6—type 1 diabetes mellitus	0.000341	0.000444	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—HLA-A—type 1 diabetes mellitus	0.00034	0.000443	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—CRP—type 1 diabetes mellitus	0.000339	0.000442	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 signaling—IL6—type 1 diabetes mellitus	0.000339	0.000442	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000338	0.00044	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—B2M—type 1 diabetes mellitus	0.000333	0.000434	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—STAT3—type 1 diabetes mellitus	0.000331	0.000432	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000325	0.000424	CbGpPWpGaD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—type 1 diabetes mellitus	0.000319	0.000415	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 interactions—IL6—type 1 diabetes mellitus	0.000319	0.000415	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR in disease—IL6—type 1 diabetes mellitus	0.000319	0.000415	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—HLA-DPB1—type 1 diabetes mellitus	0.000319	0.000415	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR—IL6—type 1 diabetes mellitus	0.000316	0.000412	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000316	0.000412	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000315	0.00041	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—HLA-E—type 1 diabetes mellitus	0.000314	0.000409	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR in Cancer—IL6—type 1 diabetes mellitus	0.000313	0.000408	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—HLA-DRB1—type 1 diabetes mellitus	0.000312	0.000406	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by PDGF—IL6—type 1 diabetes mellitus	0.000312	0.000406	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000311	0.000405	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—STAT3—type 1 diabetes mellitus	0.000311	0.000405	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000307	0.000401	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000307	0.000401	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CTLA4—type 1 diabetes mellitus	0.000302	0.000394	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—CD80—type 1 diabetes mellitus	0.0003	0.000391	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—NOS2—type 1 diabetes mellitus	0.000296	0.000385	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000289	0.000377	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD79A—type 1 diabetes mellitus	0.000288	0.000376	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CD80—type 1 diabetes mellitus	0.000288	0.000375	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—CD80—type 1 diabetes mellitus	0.000287	0.000374	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000286	0.000373	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—PRKCQ—type 1 diabetes mellitus	0.000283	0.000369	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—EGFR—type 1 diabetes mellitus	0.000283	0.000368	CbGpPWpGaD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—type 1 diabetes mellitus	0.000282	0.000368	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—NOS1—type 1 diabetes mellitus	0.000279	0.000363	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000275	0.000359	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—VAV1—type 1 diabetes mellitus	0.000275	0.000358	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—INS—type 1 diabetes mellitus	0.000271	0.000353	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—HLA-DQA1—type 1 diabetes mellitus	0.000266	0.000347	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000261	0.000341	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—PRKCQ—type 1 diabetes mellitus	0.000261	0.00034	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.00026	0.000338	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—VAV1—type 1 diabetes mellitus	0.000254	0.000331	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—TYK2—type 1 diabetes mellitus	0.000253	0.00033	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—HLA-DQB1—type 1 diabetes mellitus	0.000249	0.000324	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000248	0.000324	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000244	0.000318	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000244	0.000318	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000243	0.000316	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000243	0.000316	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—TYK2—type 1 diabetes mellitus	0.000242	0.000316	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000241	0.000314	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD86—type 1 diabetes mellitus	0.00024	0.000312	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—NOS3—type 1 diabetes mellitus	0.000238	0.00031	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD40LG—type 1 diabetes mellitus	0.000235	0.000306	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD8A—type 1 diabetes mellitus	0.000232	0.000303	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—IL6—type 1 diabetes mellitus	0.000232	0.000302	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—CD4—type 1 diabetes mellitus	0.000229	0.000298	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—HLA-B—type 1 diabetes mellitus	0.000223	0.000291	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CD86—type 1 diabetes mellitus	0.000221	0.000288	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CD4—type 1 diabetes mellitus	0.00022	0.000287	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—CD4—type 1 diabetes mellitus	0.000219	0.000285	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—IL6—type 1 diabetes mellitus	0.000217	0.000283	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—ERBB3—type 1 diabetes mellitus	0.000216	0.000281	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—SST—type 1 diabetes mellitus	0.000213	0.000278	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000212	0.000277	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL2RA—type 1 diabetes mellitus	0.000209	0.000273	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—HLA-A—type 1 diabetes mellitus	0.000207	0.00027	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000201	0.000262	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—ERBB3—type 1 diabetes mellitus	0.000199	0.00026	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CRP—type 1 diabetes mellitus	0.000197	0.000257	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CCR5—type 1 diabetes mellitus	0.000196	0.000256	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—HLA-A—type 1 diabetes mellitus	0.000191	0.000249	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—GCG—type 1 diabetes mellitus	0.00019	0.000248	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—INS—type 1 diabetes mellitus	0.00019	0.000247	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—HLA-DRB1—type 1 diabetes mellitus	0.000189	0.000246	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000184	0.000239	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000183	0.000238	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000178	0.000231	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000177	0.000231	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD80—type 1 diabetes mellitus	0.000175	0.000228	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.00017	0.000221	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—STAT3—type 1 diabetes mellitus	0.00017	0.000221	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000166	0.000217	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—NOS2—type 1 diabetes mellitus	0.000166	0.000217	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CD80—type 1 diabetes mellitus	0.000161	0.00021	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—EGFR—type 1 diabetes mellitus	0.000161	0.00021	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000161	0.00021	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000155	0.000202	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—EGFR—type 1 diabetes mellitus	0.000155	0.000202	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—EGFR—type 1 diabetes mellitus	0.000154	0.000201	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—INS—type 1 diabetes mellitus	0.000152	0.000199	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	0.000151	0.000197	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—TYK2—type 1 diabetes mellitus	0.000148	0.000192	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000147	0.000192	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	0.000142	0.000185	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000141	0.000184	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000141	0.000184	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.00014	0.000182	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IFNG—type 1 diabetes mellitus	0.000138	0.00018	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000137	0.000179	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—TYK2—type 1 diabetes mellitus	0.000136	0.000177	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000135	0.000176	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—NOS3—type 1 diabetes mellitus	0.000134	0.000174	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD4—type 1 diabetes mellitus	0.000133	0.000174	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—IL6—type 1 diabetes mellitus	0.000124	0.000161	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	0.000123	0.000161	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL1B—type 1 diabetes mellitus	0.000123	0.000161	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CD4—type 1 diabetes mellitus	0.000123	0.000161	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL2—type 1 diabetes mellitus	0.000123	0.00016	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000119	0.000155	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—IL6—type 1 diabetes mellitus	0.000118	0.000154	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000113	0.000147	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000108	0.000141	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—INS—type 1 diabetes mellitus	0.000107	0.000139	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—STAT3—type 1 diabetes mellitus	0.000103	0.000135	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000103	0.000135	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	9.75e-05	0.000127	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.54e-05	0.000124	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—STAT3—type 1 diabetes mellitus	9.54e-05	0.000124	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—EGFR—type 1 diabetes mellitus	9.39e-05	0.000122	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NOS3—type 1 diabetes mellitus	9.36e-05	0.000122	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—EGFR—type 1 diabetes mellitus	8.67e-05	0.000113	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IL6—type 1 diabetes mellitus	8.29e-05	0.000108	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	8.23e-05	0.000107	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.95e-05	0.000104	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IL2—type 1 diabetes mellitus	7.94e-05	0.000103	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	7.75e-05	0.000101	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	7.7e-05	0.0001	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	7.56e-05	9.86e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL6—type 1 diabetes mellitus	7.21e-05	9.4e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.68e-05	8.7e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—IL6—type 1 diabetes mellitus	6.66e-05	8.68e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.07e-05	7.91e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	6.03e-05	7.85e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	5.1e-05	6.65e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IL6—type 1 diabetes mellitus	4.66e-05	6.08e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	3.39e-05	4.41e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	3.1e-05	4.05e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	2.97e-05	3.87e-05	CbGpPWpGaD
